Data de publicação: 28/12/2023 - 10:12
The European Medicines Agency (EMA) has adopted a positive scientific opinion for Arpraziquantel for the treatment of schistosomiasis in preschool children (3 months to 6 years old). The application was submitted by the Pediatric Praziquantel Consortium, under the EU-M4all procedure for high-priority medicines for human use intended for countries outside the European Union. In Brazil, the regulatory submission to the Brazilian Health Regulatory...
Notícias
Data de publicação: 28/12/2023 - 09:40
The Institute of Drug Technology (Farmanguinhos/Fiocruz) has signed a technology transfer agreement for the production of the medicine tofacitinib citrate, a generic clone of Xeljanz®. The partnership was signed with Pfizer Brazil on Wednesday (12/20), in Rio de Janeiro. The aim is to strengthen national production and increase public access to the treatment of immune-mediated inflammatory diseases, i.e. those triggered by imbalances in the...
Notícias
Data de publicação: 27/12/2023 - 12:22
COVID-19 has exposed socio-economic and healthcare inequalities in Brazil, as well as the importance and weaknesses of the SUS, pointing to the need to reverse divestment in the universal public health system, a fundamental policy for reducing inequalities in the country. This is the conclusion of the article COVID-19 inpatient mortality in Brazil from 2020 to 2022: a cross-sectional overview study based on secondary data, authored by...
Notícias
Data de publicação: 27/12/2023 - 12:07
With the arrival of winter in the Amazon, there is growing concern about the diseases transmitted by Aedes aegypti, known as arboviruses. Dengue, zika and chikungunya are the most common diseases in the Amazon region, but there are also other less well-known diseases, such as the oropouche and mayaro viruses (the latter which is very common in hard-to-reach places and forest areas, with the Haemagogus janthinomys mosquito as the main vector of...
Notícias
Data de publicação: 27/12/2023 - 11:46
The Institute of Drug Technology (Farmanguinhos/Fiocruz) has taken an important step towards internationalizing its activities by signing a memorandum of understanding with the University of Coimbra (UC). International cooperation provides for the development of actions in the areas of education, research and technological development in health. Signed by the director of Farmanguinhos, Jorge Mendonça, and by the vice-dean of the...
Notícias
Data de publicação: 14/12/2023 - 16:00
In a morning of tributes, acknowledgments and commitments to public health, the director of the Pan American Health Organization (PAHO), Jarbas Barbosa, was awarded an honorary doctorate from Fiocruz by the Foundation's president, Mario Moreira. The sanitarian, a graduate of the Sergio Arouca National School of Public Health (Ensp/Fiocruz), is the seventh person to receive the most important title awarded by Fiocruz to those who work to...
Notícias
Data de publicação: 14/12/2023 - 15:38
On Thursday (12/7), Brazilian Health minister, Nísia Trindade Lima, signed a joint declaration of intent with Fiocruz's president, Mario Moreira, and the director of the Butantan Institute, Espes Kallás, to establish partnerships aimed at accelerating the development of technological platforms and local production. The signing took place during the meeting of the Executive Group of the Health Economic-Industrial Complex (Geceis...
Notícias
Data de publicação: 14/12/2023 - 15:13
Fiocruz's Antarctica Program is entering a new phase. Fioantar's proposal approved on Thursday (12/7) in a request for proposals for the next four years includes an expansion of collection points, an increase in the number of participating Foundation laboratories, a different working methodology, as well as national and international partnerships. As a result, coordinator Luciana Trilles, researcher at the Mycology Laboratory at the...
Notícias
Data de publicação: 12/12/2023 - 15:14
Research Electronic Data Capture (REDCap) (or “Electronic Data Capture Research”) is a free digital tool developed by Vanderbilt University to capture (or collect) data. Using the information acquired by the application, it is possible to support the development of health investigations. In other words, this use of data can be used to discover patterns, predict behaviours and, of course, to generate scientific knowledge through...
Notícias
Data de publicação: 12/12/2023 - 14:43
On November 28th, during an event in Rio de Janeiro, the Minister of Health Nísia Trindade Lima highlighted the "unavoidable need to strengthen national health systems" for them to be able to deal with the challenges arising from environmental changes. These emerging problems, she added, go back to the 19th and 20th centuries, and in Brazil and other countries, they continue to exist.
"There is growing awareness of the...
Notícias
Data de publicação: 12/12/2023 - 12:00
Fiocruz Amazônia, in partnership with the Federal University of Amazonas (Ufam) and the French Research Institute for Development, has carried out a study with an unprecedented approach to assess the relationship between the color of rivers and the incidence of malaria. According to the research, a relationship was observed between the two factors, which is why, in extreme situations, localities near black colored rivers have a higher...
Notícias
Data de publicação: 12/12/2023 - 11:35
In yet another step in the history of the partnership between Angola and Fiocruz, the Foundation received, on 11/27, a delegation from the Angolan Ministry of Health to continue planning cooperation actions between the institutions, with a focus on training health professionals. The visit took place two weeks after a delegation from Fiocruz visited the African country on a prospecting mission for the Brazilian Ministry of Health (MS). The trips...
Notícias
Data de publicação: 11/12/2023 - 16:41
Fiocruz, through the Institute of Drug Technology (Farmanguinhos), signed a technical and scientific cooperation agreement on 12/04 to register a generic clone drug for the treatment of Chagas disease with the Brazilian Health Regulatory Agency (Anvisa). The partnership was signed with the German multinational Bayer AG, which owns Nifurtimox®, indicated for the treatment of the disease, with registration approved in the United States,...
Notícias
Data de publicação: 08/12/2023 - 16:32
Fiocruz's president Mario Moreira signed a Memorandum of Understanding (MoU) with the Robert Koch Institute (RKI) in Berlin on Monday (12/04) for collaboration in research, surveillance, technological development and innovation. The agreement was signed by the vice president of the Robert Koch Institute (RKI) and director of the Center for International Health Protection (ZIG), Johanna Hanefeld, in the presence of Brazil's Minister of...
Notícias
Data de publicação: 05/12/2023 - 16:48
The president of Fiocruz, Mario Moreira, and the Chilean Minister of Health, Ximena Aguilera, signed a Memorandum of Understanding (MoU) on Wednesday (11/28) which paves the way for cooperation in education, research and development, as well as communication, information, management and policies in the field of health in general. Accompanied by the head of the Office of Cooperation and International Affairs, Raquel Child Goldenberg, and the...
Notícias
Data de publicação: 05/12/2023 - 16:21
The G20 (Group of Twenty) is an international forum comprising the countries with the largest economies in the world, which currently plays a central role in coordinating economic policies with a global impact and which aims, at least rhetorically, to promote inclusive growth, reduce inequalities and respond to global challenges. Since its creation in 1999, the group has played a key role in promoting cooperation and finding joint...
Notícias
Data de publicação: 30/11/2023 - 11:55
After nine years of effort, experts have completed the development of a standardized and validated methodology for the molecular diagnosis of cutaneous leishmaniasis in the Americas. Advances in diagnosis could help control the disease, which is considered neglected by the World Health Organization (WHO). The infection causes sores on the skin, damaging patients' quality of life both due to the impact of the lesions and the stigma. The...
Notícias
Data de publicação: 30/11/2023 - 11:34
Four years after arriving for the first time in Antarctica, Fioantar began, last Wednesday (11/21), the last expeditions planned in the first 2019-2024 public notice from the CNPq/Ministry of Science, Technology, and Innovation (MCTI). Researchers Adriana Marcos Vivoni, Maithê Magalhães and Lucas Machado Moreira boarded a Brazilian Air Force plane, along with journalist Matheus Cruz and engineers Armando Carlos Lopes and Carlos...
Notícias
Data de publicação: 29/11/2023 - 16:05
The multidimensional crisis, which encompasses the economic, social, environmental, health and even ethical areas, caused by the COVID-19 pandemic, is the main theme of the book Perpectivas y desafíos en un enscenario post pandemia, adressing the health and the health system situation in Latin America. The e-book edited by the Latin American Alliance for Global Health (Alasag), with the support of the Center for International Relations in...
Notícias
Data de publicação: 29/11/2023 - 10:17
Fiocruz will host the next Pasteur Network Annual Meeting (PNAM), a vast scientific community with over 30 members in more than 20 countries, in which the Foundation has participated since 2009 and became an official member in 2015. The announcement was made during this year's edition, which took place in Tunis, Tunisia, between November 19 and 21, and whose main themes included infectious diseases and pandemic preparedness with a focus on...
Notícias
Data de publicação: 24/11/2023 - 12:20
This Friday (11/17), Fiocruz, through the Immunobiological Technology Institute (Bio-Manguinhos/Fiocruz) signed a Term of Commitment with the National Administration of Laboratories and Institutes of Health Dr. Carlos Malbrán (Anlis), aimed at enabling the Argentine institution to produce and supply the yellow fever vaccine in its country. The signing took place after the meeting of Mercosur health ministers at Itamaraty, in Brasí...
Notícias
Data de publicação: 24/11/2023 - 11:36
Between 5 and 10 million people. This is the estimate, according to the United Nations (UN), of people infected by HTLV-1 or Human T-cell lymphotropic virus in the world. According to Fiocruz, the regions with the highest prevalence are Africa, Latin America, and the Caribbean, as well as Japan and Australia. But data on the disease is underreported, and the virus is still little known both amongst the population and health professionals.
To...
Notícias
Data de publicação: 18/11/2023 - 14:55
The Joint Steering Committee of the Dengue Alliance met last week at Fiocruz to exchange experiences and align important points to advance toward the goal of having a new treatment accessible from already approved drugs - and their combinations - for dengue within five years. At the meeting, which took place between November 8 and 10, it was possible to make progress in the debate on the selection of a drug candidate for clinical trials and the...
Notícias
Data de publicação: 14/11/2023 - 11:16
For a week, French was the second most spoken language at Fiocruz. A delegation from the Sorbonne University visited the Foundation from the 23rd to the 27th of october to discuss prospects for collaboration. In addition to the meetings between the directors, a five-day seminar promoted scientific sessions that brought researchers from both sides closer together. Covering subjects ranging from neuromuscular diseases to immunotherapy with CAR-T...
Notícias
Data de publicação: 13/11/2023 - 16:43
During a mission to Germany in October (10/16 to 20), Fiocruz president Mario Moreira and vice-president of Research and Biological Collections Maria de Lourdes Oliveira made official visits to three institutions: the Robert Koch Institute; Charité; and the Paul Ehrlich Institute. The aim was to map out the possibilities for synergy between the actions of Fiocruz and the German institutes for future partnerships, especially in the areas...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
